Skip to search formSkip to main contentSkip to account menu

IFN-DTIC Regimen

Known as: Interferon-Dacarbazine Regimen 
A chemoimmunotherapy regimen consisting of interferon and dacarbazine used for the treatment of advanced-stage or metastatic malignant melanoma.
National Institutes of Health

Related topics

Related topics

3 relations
DacarbazineRecombinant Interferonmelanoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Our experience with interferon alpha: metastatic malignant melanoma.
Interferon-alpha and dacarbazine combination is a milestone in the treatment of metastatic malignant melanoma. Objective response… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)